Cargando…

Activation of STAT3 and STAT5 Signaling in Epithelial Ovarian Cancer Progression: Mechanism and Therapeutic Opportunity

Epithelial ovarian cancer (EOC) is the most lethal of all gynecologic malignancies. Despite advances in surgical and chemotherapeutic options, most patients with advanced EOC have a relapse within three years of diagnosis. Unfortunately, recurrent disease is generally not curable. Recent advances in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Chin-Jui, Sundararajan, Vignesh, Sheu, Bor-Ching, Huang, Ruby Yun-Ju, Wei, Lin-Hung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017004/ https://www.ncbi.nlm.nih.gov/pubmed/31861720 http://dx.doi.org/10.3390/cancers12010024

Ejemplares similares

STAT3 signaling in ovarian cancer: a potential therapeutic target
por: Liang, Renba, et al.
Publicado: (2020)

JAK/STAT Signaling: Molecular Targets, Therapeutic Opportunities, and Limitations of Targeted Inhibitions in Solid Malignancies
por: Rah, Bilal, et al.
Publicado: (2022)

Spotlight on the Granules (Grainyhead-Like Proteins) – From an Evolutionary Conserved Controller of Epithelial Trait to Pioneering the Chromatin Landscape
por: Sundararajan, Vignesh, et al.
Publicado: (2020)

Sonographic features differentiating early-stage ovarian clear cell carcinoma from endometrioma with atypical features
por: Huang, Kuan-Ju, et al.
Publicado: (2022)

Type I IFN induced IL1-Ra expression in hepatocytes is mediated by activating STAT6 through the formation of STAT2: STAT6 heterodimer
por: Wan, Lei, et al.
Publicado: (2008)

Signaling by STATs
por: Ivashkiv, Lionel B, et al.
Publicado: (2004)

SPTBN1 suppresses the progression of epithelial ovarian cancer via SOCS3-mediated blockade of the JAK/STAT3 signaling pathway
por: Chen, Mo, et al.
Publicado: (2020)

STAT3-Activating Cytokines: A Therapeutic Opportunity for Inflammatory Bowel Disease?
por: Nguyen, Paul M., et al.
Publicado: (2015)

Ultrasound reduces inflammation by modulating M1/M2 polarization of microglia through STAT1/STAT6/PPARγ signaling pathways
por: Hsu, Chin‐Hung, et al.
Publicado: (2023)

Redox Regulation of STAT1 and STAT3 Signaling
por: Butturini, Elena, et al.
Publicado: (2020)

The Role and Therapeutic Targeting of JAK/STAT Signaling in Glioblastoma
por: Ou, Alexander, et al.
Publicado: (2021)

The potential roles of JAK/STAT signaling in the progression of osteoarthritis
por: Zhou, Qingluo, et al.
Publicado: (2022)

STAT signaling in inflammation
por: Kaplan, Mark H.
Publicado: (2013)

Fertility and Pregnancy Outcomes after Fertility-Sparing Surgery for Early-Stage Borderline Ovarian Tumors and Epithelial Ovarian Cancer: A Single-Center Study
por: Ko, Mu-En, et al.
Publicado: (2023)

SNAI1 recruits HDAC1 to suppress SNAI2 transcription during epithelial to mesenchymal transition
por: Sundararajan, Vignesh, et al.
Publicado: (2019)

The Multifaceted Roles of STAT3 Signaling in the Progression of Prostate Cancer
por: Bishop, Jennifer L., et al.
Publicado: (2014)

Editorial: The role of STAT3 signaling pathway in tumor progression
por: Chang, Nan-Shan, et al.
Publicado: (2023)

Targeting SHP-1-STAT3 signaling: A promising therapeutic approach for the treatment of cholangiocarcinoma
por: Hu, Ming-Hung, et al.
Publicado: (2017)

Signal Transducer and Activator of Transcription (STATs) Proteins in Cancer and Inflammation: Functions and Therapeutic Implication
por: Loh, Chin-Yap, et al.
Publicado: (2019)

Expression of tSTAT3, pSTAT3(727), and pSTAT3 (705) in the epithelial cells of hormone‐naïve prostate cancer
por: Krzyzanowska, Agnieszka, et al.
Publicado: (2019)

STAT3 and epithelial–mesenchymal transitions in carcinomas
por: Wendt, Michael K, et al.
Publicado: (2014)

Phosphorylation of STAT3 at Tyr705 regulates MMP-9 production in epithelial ovarian cancer
por: Jia, Zan-Hui, et al.
Publicado: (2017)

IL-4 and IL-13 Promote Proliferation of Mammary Epithelial Cells through STAT6 and IRS-1
por: Wu, Wan-Ju, et al.
Publicado: (2021)

Role of Jagged1/STAT3 signalling in platinum‐resistant ovarian cancer
por: Yang, Jiang, et al.
Publicado: (2019)

STAT2 phosphorylation and signaling
por: Steen, Håkan C, et al.
Publicado: (2013)

Eriocalyxin B Inhibits STAT3 Signaling by Covalently Targeting STAT3 and Blocking Phosphorylation and Activation of STAT3
por: Yu, Xiaokui, et al.
Publicado: (2015)

STAT3 can be activated through paracrine signaling in breast epithelial cells
por: Lieblein, Jacqueline C, et al.
Publicado: (2008)

Requirement of Stat3 Signaling in the Postnatal Development of Thymic Medullary Epithelial Cells
por: Satoh, Rumi, et al.
Publicado: (2016)

Stat3 Signaling Promotes Survival And Maintenance Of Medullary Thymic Epithelial Cells
por: Lomada, Dakshayani, et al.
Publicado: (2016)

Significance of Stat3 Signaling in Epithelial Cell Differentiation of Fetal Mouse Lungs
por: Kameyama, Hiroki, et al.
Publicado: (2017)

Pharmacological Inhibition of Oncogenic STAT3 and STAT5 Signaling in Hematopoietic Cancers
por: Brachet-Botineau, Marie, et al.
Publicado: (2020)

Pharmacological Targeting SHP-1-STAT3 Signaling Is a Promising Therapeutic Approach for the Treatment of Colorectal Cancer()()
por: Fan, Li-Ching, et al.
Publicado: (2015)

Long-term follow-up of 453 patients with pelvic organ prolapse who underwent transvaginal sacrospinous colpopexy with Veronikis ligature carrier
por: Wu, Chin-Jui, et al.
Publicado: (2020)

STAT3 Signaling in Breast Cancer: Multicellular Actions and Therapeutic Potential
por: To, Sarah Q., et al.
Publicado: (2022)

JAK/STAT pathway: Extracellular signals, diseases, immunity, and therapeutic regimens
por: Hu, Qian, et al.
Publicado: (2023)

JAK-STAT Pathway Regulation of Intestinal Permeability: Pathogenic Roles and Therapeutic Opportunities in Inflammatory Bowel Disease
por: Lei, Hillmin, et al.
Publicado: (2021)

Multicellular Effects of STAT3 in Non-small Cell Lung Cancer: Mechanistic Insights and Therapeutic Opportunities
por: Parakh, Sagun, et al.
Publicado: (2021)

STAT3 and STAT5A are potential therapeutic targets in castration-resistant prostate cancer
por: Mohanty, Sambit K., et al.
Publicado: (2017)

Early responses of the STAT3 pathway to platinum drugs are associated with cisplatin resistance in epithelial ovarian cancer
por: Sheng, W.J., et al.
Publicado: (2013)

Targeting constitutively-activated STAT3 in hypoxic ovarian cancer, using a novel STAT3 inhibitor
por: McCann, Georgia A., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_6odlkgjctamc868cj90iqe2qe5